Nikolaos Reskos sells SBLK shares under 10b5-1 plan (SBLK)

Rhea-AI Filing Summary

SBLK: Nikolaos Reskos reported proposed or completed sales of Common Stock via a 10b5-1 plan and other dispositions. The filing lists multiple transactions on 05/18/2026, 05/19/2026, 05/20/2026, 04/14/2026, and 04/15/2026, with individual share amounts and proceeds shown per date.

Insights

Corporate Governance Analyst

Director-level sales via a pre-arranged plan were reported.

The excerpt lists multiple dispositions by Nikolaos Reskos, some explicitly labeled "10b5-1 Sales," indicating at least part of the activity was conducted under a pre-arranged trading plan. Reported rows include dates, share counts, and gross proceeds.

Timing and amounts are factual in the excerpt; subsequent filings may show net holdings or additional context such as remaining beneficial ownership.

Key Figures

Sale on 05/18/2026: 33,103 shares Proceeds on 05/18/2026: $868,179.15 Sale on 05/20/2026: 9,914 shares +3 more

6 metrics

Sale on 05/18/2026 33,103 shares reported sale on 05/18/2026

Proceeds on 05/18/2026 $868,179.15 gross proceeds from 33,103-share sale

Sale on 05/20/2026 9,914 shares 10b5-1 sale on 05/20/2026

Proceeds on 05/20/2026 $263,234.55 gross proceeds from 9,914-share sale

Sale on 05/19/2026 86 shares 10b5-1 sale on 05/19/2026

Awarded shares 30,000 shares Employee Stock Unit Award dated 09/16/2020

Key Terms

10b5-1, Employee Stock Unit Award, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Employee Stock Unit Award financial

"Employee Stock Unit Award | Issuer | 30000 | 09/16/2020"

Form 144 regulatory

"form_type: "144" in metadata"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	800700.00	113424507	05/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2020	Employee Stock Unit Award	Issuer			30000	09/16/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/20/2026	9914	263234.55
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/19/2026	86	2278.14
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/18/2026	33103	868179.15
NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	04/15/2026	8406	210570.30
NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	04/14/2026	1594	39850.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales did Nikolaos Reskos report for SBLK?

The filing lists multiple sales by Nikolaos Reskos, including 33,103 shares on 05/18/2026 for $868,179.15 and 9,914 shares on 05/20/2026 for $263,234.55, with additional smaller sales on 04/14/2026, 04/15/2026, and 05/19/2026.

Were any of the SBLK transactions made under a 10b5-1 plan?

Yes. The excerpt explicitly labels some transactions as 10b5-1 Sales, including entries on 05/18/2026, 05/19/2026, and 05/20/2026, indicating those trades were effected under a pre-arranged trading plan.

How many shares are shown as available under the reported award or holding?

The filing shows a line item of 30,000 Common shares associated with an Employee Stock Unit Award dated 09/16/2020, listed under securities information in the excerpt.

What proceeds were reported for the largest sale listed?

The largest single line in the excerpt shows $868,179.15 for 33,103 shares on 05/18/2026, as reported in the provided table of transactions.

Does this filing state how these sales affect Reskos's remaining holdings?

The excerpt provides per-transaction share counts and gross proceeds but does not state the post-transaction beneficial ownership balance or remaining holdings in the visible content.